These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 16325515)

  • 21. Expression of survivin, an inhibitor of apoptosis protein, in tumors of the nervous system.
    Sasaki T; Lopes MB; Hankins GR; Helm GA
    Acta Neuropathol; 2002 Jul; 104(1):105-9. PubMed ID: 12070671
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ultrarapid Ki-67 immunostaining in frozen section interpretation of gliomas.
    Haapasalo J; Mennander A; Helen P; Haapasalo H; Isola J
    J Clin Pathol; 2005 Mar; 58(3):263-8. PubMed ID: 15735157
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cyclooxygenase-2 in oligodendroglial neoplasms.
    Castilla EA; Prayson RA; Kanner AA; Rybicki LA; Tubbs RR; Vogelbaum MA; Barnett GH
    Cancer; 2003 Oct; 98(7):1465-72. PubMed ID: 14508834
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Patterns of MiB-1 staining of brain tumors: microwave-antigen retrieval as a tool in diagnostic pathology.
    Meera G; Jo H; Ravi R
    Eur J Morphol; 1995 Nov; 33(4):337-58. PubMed ID: 8835134
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Ki-67 proliferation antigen in meningiomas. Experience in 600 cases.
    Roser F; Samii M; Ostertag H; Bellinzona M
    Acta Neurochir (Wien); 2004 Jan; 146(1):37-44; discussion 44. PubMed ID: 14740263
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High-throughput immunohistochemical profiling of primary brain tumors and non-neoplastic systemic organs with a specific antibody against the mutant isocitrate dehydrogenase 1 R132H protein.
    Ikota H; Nobusawa S; Tanaka Y; Yokoo H; Nakazato Y
    Brain Tumor Pathol; 2011 Apr; 28(2):107-14. PubMed ID: 21213123
    [TBL] [Abstract][Full Text] [Related]  

  • 27. p53 protein expression in central nervous system tumors: an immunohistochemical study with CM1 polyvalent and DO-7 monoclonal antibodies.
    Karamitopoulou E; Perentes E; Diamantis I
    Acta Neuropathol; 1993; 85(6):611-6. PubMed ID: 8337939
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Microwave-assisted antigen retrieval and incubation with cox-2 antibody of archival paraffin-embedded human oligodendroglioma and astrocytomas.
    Temel SG; Minbay FZ; Kahveci Z; Jennes L
    J Neurosci Methods; 2006 Sep; 156(1-2):154-60. PubMed ID: 16621014
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MIB-1 labeling index in astrocytic tumors--a clinicopathologic study.
    Neder L; Colli BO; Machado HR; Carlotti CG; Santos AC; Chimelli L
    Clin Neuropathol; 2004; 23(6):262-70. PubMed ID: 15584210
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Quantification of sensitivity of endothelial cell markers for the astrocytoma and oligodendroglioma tumours.
    Aronsson DE; Muhr C
    Anticancer Res; 2002; 22(1A):343-6. PubMed ID: 12017315
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interobserver variability in determining MIB-1 labeling indices in oligodendrogliomas.
    Prayson RA; Castilla EA; Hembury TA; Liu W; Noga CM; Prok AL
    Ann Diagn Pathol; 2003 Feb; 7(1):9-13. PubMed ID: 12616468
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunohistochemical detection of proliferating cell nuclear antigen and Ki-67 in mast cell tumors from dogs.
    Abadie JJ; Amardeilh MA; Delverdier ME
    J Am Vet Med Assoc; 1999 Dec; 215(11):1629-34. PubMed ID: 14567425
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Correlation of bcl-2, p53, and MIB-1 expression with ependymoma grade and subtype.
    Rushing EJ; Brown DF; Hladik CL; Risser RC; Mickey BE; White CL
    Mod Pathol; 1998 May; 11(5):464-70. PubMed ID: 9619600
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of gliomas by morphological and immunocytochemical analysis in cell cultures.
    Fazekas I; Kerekes E; Hegedús B; Nyáry I
    Ideggyogy Sz; 2002 May; 55(5-6):173-9. PubMed ID: 12122877
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Comparative studies on the biological significance of the marker for proliferation Ki-67-Antigen and PCNA in primary ovarian carcinoma].
    Reitmaier M; Rudlowski C; Biesterfeld S; Rath W; Schröder W
    Zentralbl Gynakol; 2000; 122(7):361-7. PubMed ID: 10951706
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Progression of astrocytomas and meningiomas: an evaluation in vitro.
    Maes L; Kalala JP; Cornelissen M; de Ridder L
    Cell Prolif; 2007 Feb; 40(1):14-23. PubMed ID: 17227292
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The growth potential of ependymomas with varying grades of malignancy measured by the Ki-67 labelling index and mitotic index.
    Schröder R; Ploner C; Ernestus RI
    Neurosurg Rev; 1993; 16(2):145-50. PubMed ID: 8345908
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Tissue transglutaminase protein expression in human brain tumors].
    Wang R; Yang WZ; Shi SS; Yang FD
    Zhonghua Bing Li Xue Za Zhi; 2003 Feb; 32(1):31-4. PubMed ID: 12760800
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The relationship between Ki-67 labeling and mitotic index in gliomas and meningiomas: demonstration of the variability of the intermitotic cycle time.
    Schröder R; Bien K; Kott R; Meyers I; Vössing R
    Acta Neuropathol; 1991; 82(5):389-94. PubMed ID: 1767633
    [TBL] [Abstract][Full Text] [Related]  

  • 40. PCNA and Ki-67 in central nervous system tumors: correlation with the histological type and grade.
    Kayaselçuk F; Zorludemir S; Gümürdühü D; Zeren H; Erman T
    J Neurooncol; 2002 Apr; 57(2):115-21. PubMed ID: 12125971
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.